NEW YORK (TheStreet) -- Shares of Nu Skin Enterprises (NUS) were falling 15% to $50.38 on heavy trading volume Thursday after the personal care products and dietary supplements company missed analysts' estimates for earnings and revenue in the first quarter.
Nu Skin reported earnings of 72 cents a share for the first quarter, missing analysts' estimates of 73 cents a share for the quarter. Revenue fell 19% year over year to $543.33 million for the quarter, below analysts' estimates of $544.65 million.
Looking to the second quarter Nu Skin expects to report earnings of 72 cents to 75 cents a share and revenue of $540 million to $560 million. Analysts expect the company to report earnings of 93 cents and revenue of $608.73 million for the quarter.
Nu Skin expects earnings of $3.65 to $3.75 and revenue of $2.45 billion to $2.5 billion for full year 2015. Analysts expect the company to report earnings of $3.95 a share and revenue of $2.53 for the full year.
About 2 million shares of Nu Skins were traded by 10:24 a.m. Thursday, above the company's average trading volume of about 941,000 shares a day.
TheStreet Ratings team rates NU SKIN ENTERPRISES as a Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:
"We rate NU SKIN ENTERPRISES (NUS) a HOLD. The primary factors that have impacted our rating are mixed -- some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself."